Zavala, Valentina A.
Bracci, Paige M.
Carethers, John M.
Carvajal-Carmona, Luis http://orcid.org/0000-0001-7129-2918
Coggins, Nicole B.
Cruz-Correa, Marcia R.
Davis, Melissa
de Smith, Adam J.
Dutil, Julie
Figueiredo, Jane C.
Fox, Rena
Graves, Kristi D.
Gomez, Scarlett Lin
Llera, Andrea
Neuhausen, Susan L.
Newman, Lisa
Nguyen, Tung
Palmer, Julie R.
Palmer, Nynikka R.
Pérez-Stable, Eliseo J.
Piawah, Sorbarikor
Rodriquez, Erik J.
Sanabria-Salas, María Carolina
Schmit, Stephanie L.
Serrano-Gomez, Silvia J.
Stern, Mariana C.
Weitzel, Jeffrey
Yang, Jun J. http://orcid.org/0000-0002-0770-9659
Zabaleta, Jovanny
Ziv, Elad
Fejerman, Laura http://orcid.org/0000-0003-3179-1151
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (R01CA204797)
Article History
Received: 14 November 2019
Revised: 16 July 2020
Accepted: 3 August 2020
First Online: 9 September 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Not applicable.
: The authors declare no competing interests.
: Investigators participating in this review would like to acknowledge their funding sources: L. Fejerman was supported by NIH/NCI (R01CA204797 to LF), the UCSF Helen Diller Family Comprehensive Cancer Center through the San Francisco Cancer Initiative (SF CAN) and the California Initiative to Advance Precision Medicine (CA-OPR18111 to L.C.-C., E.Z. and S.L.N.). V. Zavala was supported by NIH/NCI (R01CA204797 to L.F.). Bracci was supported by NIH–NCI grants (R01CA1009767, R01CA109767-S1, R01CA059706 and R01CA154823) and the Joan Rombauer Pancreatic Cancer Fund. J. Carethers was supported by the United States Public Health Service (NIH grant CA206010) and the A. Alfred Taubman Medical Research Institute of the University of Michigan. L. Carvajal-Carmona was supported by NIH/NCI (R01CA223978, U54CA233306, P30CA093373 and R21CA199631) and The Auburn Community Cancer Endowed Chair in Basic Science. M. Correa was supported by NIH/NIMHD and NIAID (U54MD007587). J. Dutil was supported by SC1 GM127276-05 and U54 CA163071 grants. S. Schmit and J. Figueiredo were supported by NIH/NCI (R01CA238087). R. Fox, T. Nguyen and S. Piawah were supported by UCSF Helen Diller Family Comprehensive Cancer Center through SF CAN. K. Graves was supported by Survivorship Research Initiative through NCI grant (P30-CA051008). A. Llera was supported by CONICET, Argentina and the Center for Global Health, NCI. S. Neuhausen was supported by the California Initiative to Advance Precision Medicine (CA-OPR18111 to L.C.-C., E.Z. and S.L.N.), NIH/NCI (R01CA184585 to S.L.N. and E.Z.) and Morris and Horowitz Families Endowed Professorship. L. Newman was supported by Komen Scholars Leadership Grant (SAC160072) and the Fashion Footwear Association of New York Charitable Foundation. J.R. Palmer was supported by NIH/NCI (R01CA228357 to J.R.P. and U01CA164974 to L.R. and J.R.P.) by a Susan G. Komen Foundation Leadership Grant (SAC180086), and by the Karin Grunebaum Foundation. N.R. Palmer was supported by NIH/NCI (K01CA211965) and the UCSF Helen Diller Family Comprehensive Cancer Center through SF CAN. E. Perez-Stable and E.J. Rodriquez were supported by NHLBI and NIMHD Divisions of Intramural Research. M.C. Sanabria was supported by the Instituto Nacional de Cancerología, Colombia (19010300411). S. Serrano was supported by Colciencias (19010300431). M. Stern was supported by NCI grant (P30CA014089). J. Weitzel was supported in part by Award (BCRF-16-168), from The Breast Cancer Research Foundation, the Dr. Norman & Melinda Payson Professorship in Medical Oncology and the Conquer Cancer Research Professorship in Breast Cancer Disparities. J. Yang was supported by NIGMS (R01-5R01GM118578-04) and CPML-5 (P50GM115279-05). J. Zabaleta was supported by NH/NIGMS grants (P30GM114732 to Ochoa, 1P20GM121288 to Reiss and NIH/NCI 1P20CA202922-01A1 to Miele).